Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study

Giuseppe Leone, X Thomas, S Suciu, B Rio, G Broccia, G Fillet, U Jehn, W Feremans, G Meloni, M Vignetti, T De Witte, S. Amadori

Risultato della ricerca: Contributo in rivistaArticolo in rivista

33 Citazioni (Scopus)

Abstract

The optimal post-remission treatment for elderly patients with acute myeloid leukemia (AML) is presently unknown. Recent studies have reported the feasibility of autologous peripheral blood stem cell transplantation (PBSCT) in this population. We evaluate the outcome of this post-remission approach after complete remission (CR) and consolidation in elderly patients included in the EORTC-GIMEMA AML-13 trial.
Lingua originaleEnglish
pagine (da-a)389-396
Numero di pagine8
RivistaHaematologica
Volume92
Stato di pubblicazionePubblicato - 2007
Pubblicato esternamenteYes

Keywords

  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Amsacrine
  • Antineoplastic Combined Chemotherapy Protocols
  • Carmustine
  • Combined Modality Therapy
  • Cytarabine
  • Disease-Free Survival
  • Etoposide
  • Feasibility Studies
  • Female
  • Graft Survival
  • Granulocyte Colony-Stimulating Factor
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Idarubicin
  • Infusions, Intravenous
  • Injections, Subcutaneous
  • Kaplan-Meier Estimate
  • Leukemia, Myeloid
  • Male
  • Middle Aged
  • Peripheral Blood Stem Cell Transplantation
  • Prospective Studies
  • Recombinant Proteins
  • Survival Analysis
  • Transplantation Conditioning
  • Transplantation, Autologous
  • Treatment Outcome

Fingerprint Entra nei temi di ricerca di 'Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study'. Insieme formano una fingerprint unica.

Cita questo